These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 7607504)
1. Genomic sequencing indicates a correlation between DNA hypomethylation in the 5' region of the pS2 gene and its expression in human breast cancer cell lines. Martin V; Ribieras S; Song-Wang X; Rio MC; Dante R Gene; 1995 May; 157(1-2):261-4. PubMed ID: 7607504 [TBL] [Abstract][Full Text] [Related]
2. Involvement of DNA methylation in the control of the expression of an estrogen-induced breast-cancer-associated protein (pS2) in human breast cancers. Martin V; Ribieras S; Song-Wang XG; Lasne Y; Frappart L; Rio MC; Dante R J Cell Biochem; 1997 Apr; 65(1):95-106. PubMed ID: 9138084 [TBL] [Abstract][Full Text] [Related]
3. Structure of the human oestrogen-responsive gene pS2. Jeltsch JM; Roberts M; Schatz C; Garnier JM; Brown AM; Chambon P Nucleic Acids Res; 1987 Feb; 15(4):1401-14. PubMed ID: 3822834 [TBL] [Abstract][Full Text] [Related]
4. Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines. Giamarchi C; Solanas M; Chailleux C; Augereau P; Vignon F; Rochefort H; Richard-Foy H Oncogene; 1999 Jan; 18(2):533-41. PubMed ID: 9927210 [TBL] [Abstract][Full Text] [Related]
5. The estrogen responsive element of the pS2 gene is recognized by a methylation sensitive DNA binding protein. Martin V; Ribieras S; Rio MC; Dante R Biol Chem; 1998; 379(4-5):409-16. PubMed ID: 9628331 [TBL] [Abstract][Full Text] [Related]
6. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312 [TBL] [Abstract][Full Text] [Related]
7. Expression of the pS2 gene in human gastric cancer cells derived from poorly differentiated adenocarcinoma. Takahashi H; Kida N; Fujii R; Tanaka K; Ohta M; Mori K; Hayashi K FEBS Lett; 1990 Feb; 261(2):283-6. PubMed ID: 2311759 [TBL] [Abstract][Full Text] [Related]
8. Methylation of CpGs as a determinant of transcriptional activation at alternative promoters for transforming growth factor-beta3. Archey WB; Sweet MP; Alig GC; Arrick BA Cancer Res; 1999 May; 59(10):2292-6. PubMed ID: 10344731 [TBL] [Abstract][Full Text] [Related]
9. Complete primary structure of the human estrogen-responsive gene (pS2) product. Mori K; Fujii R; Kida N; Takahashi H; Ohkubo S; Fujino M; Ohta M; Hayashi K J Biochem; 1990 Jan; 107(1):73-6. PubMed ID: 2185238 [TBL] [Abstract][Full Text] [Related]
10. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801 [TBL] [Abstract][Full Text] [Related]
11. The pS2 gene, mRNA, and protein: a potential marker for human breast cancer. Rio MC; Chambon P Cancer Cells; 1990; 2(8-9):269-74. PubMed ID: 2223388 [TBL] [Abstract][Full Text] [Related]
12. Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors. Zheng S; Chen P; McMillan A; Lafuente A; Lafuente MJ; Ballesta A; Trias M; Wiencke JK Carcinogenesis; 2000 Nov; 21(11):2057-64. PubMed ID: 11062168 [TBL] [Abstract][Full Text] [Related]
13. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling. Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620 [TBL] [Abstract][Full Text] [Related]
14. The 5' flanking region of the human pS2 gene mediates its transcriptional activation by estrogen in MCF-7 cells. Roberts M; Wallace J; Jeltsch JM; Berry M Biochem Biophys Res Commun; 1988 Feb; 151(1):306-13. PubMed ID: 2450536 [TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Dammann R; Yang G; Pfeifer GP Cancer Res; 2001 Apr; 61(7):3105-9. PubMed ID: 11306494 [TBL] [Abstract][Full Text] [Related]
16. DNA methylation status of the MUC1 gene coding for a breast-cancer-associated protein. Zrihan-Licht S; Weiss M; Keydar I; Wreschner DH Int J Cancer; 1995 Jul; 62(3):245-51. PubMed ID: 7628867 [TBL] [Abstract][Full Text] [Related]
17. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Pulukuri SM; Rao JS Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000 [TBL] [Abstract][Full Text] [Related]
18. The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. Nunez AM; Berry M; Imler JL; Chambon P EMBO J; 1989 Mar; 8(3):823-9. PubMed ID: 2498085 [TBL] [Abstract][Full Text] [Related]
19. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622 [TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor-dependent formation of two distinct multiprotein complexes on the human pS2 gene regulatory segment. Participation of a c-fos related protein. Schuh TJ; Mueller GC Receptor; 1993; 3(2):125-43. PubMed ID: 8251952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]